Karyopharm Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Karyopharm Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2013 to Q3 2024.
  • Karyopharm Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$5.76M, a 78.1% decline year-over-year.
  • Karyopharm Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $38.8M.
  • Karyopharm Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was -$13.2M, a 41.7% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was -$22.7M, a 11.1% increase from 2021.
  • Karyopharm Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was -$25.5M, a 5.95% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $38.8M -$5.76M -$2.53M -78.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $41.3M $52M +$54.9M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$13.6M -$3.53M -$359K -11.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$13.2M -$3.9M +$665K +14.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$13.9M -$3.23M +$2.21M +40.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$16.1M -$2.93M +$3.1M +51.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$19.2M -$3.17M +$3.51M +52.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$22.7M -$4.56M +$3.8M +45.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$26.5M -$5.44M +$2.45M +31.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$29M -$6.03M -$1.63M -37.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$27.3M -$6.68M -$1.79M -36.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$25.5M -$8.36M -$2.07M -32.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$23.5M -$7.89M -$1.55M -24.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$21.9M -$4.4M +$1.57M +26.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$23.5M -$4.89M +$617K +11.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$24.1M -$6.29M -$914K -17% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 -$23.2M -$6.34M -$4.4M -226% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$18.8M -$5.97M -$4.25M -247% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$14.6M -$5.51M -$4.28M -348% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$10.3M -$5.38M -$4.64M -629% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$5.63M -$1.95M -$3.03M -279% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$2.6M -$1.72M -$2.38M -361% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$222K -$1.23M -$1.72M -348% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $1.5M -$738K -$1.16M -275% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $2.66M $1.09M +$657K +154% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $2M $660K +$277K +72.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.73M $495K +$110K +28.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.62M $421K +$52K +14.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $1.57M $428K +$111K +35% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.45M $383K +$65K +20.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.39M $385K +$95K +32.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.29M $369K +$112K +43.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $1.18M $317K +$80K +33.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $1.1M $318K $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $1.1M $290K +$207K +249% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $895K $257K +$243K +1736% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 $652K $237K +$217K +1085% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $435K $318K +$301K +1771% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $134K $83K +$65K +361% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $69K $14K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $20K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $17K +$16K Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $18K Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-08
Q2 2013 $1K* Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.